Light Photo Treatment at 405 nm Can Effectively Kill Leishmania Parasites
Open Access
- 16 May 2026
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 14 (5) , 1135
Abstract
Cutaneous leishmaniasis is a protozoan disease which is responsible for significant morbidity in humans. Currently, there is no clinically approved vaccine to prevent infections, and, therefore, treatments to cure skin lesions are required. Ideally, a treatment that can be self-administered to affected areas is desirable. In this study, the effect of violet-blue light, of wavelength in the region of 405 nm, on the survival of Leishmania major and Leishmania mexicana was determined using in vitro and in vivo models. Light treatment caused significant killing of both promastigotes and intracellular amastigotes (p < 0.001) of both species in vitro, and L. mexicana intracellular amastigotes were more resistant to light treatment than L. major intracellular amastigotes. Treatment with violet-blue light at a dose of 45 J/cm2 (0.15 W/cm2 for 5 min) per day on days 3–7 post-infection in an in vivo footpad model caused a significant reduction in L. major parasite burdens on day 5 post-infection (p < 0.05) in one of two experiments, though by day 10 post-infection, parasite numbers had recovered to those of controls. The results of this study clearly demonstrate that violet-blue light can kill both L. major and L. mexicana parasites, but application to infected cutaneous tissues requires refinement.Keywords
This publication has 31 references indexed in Scilit:
- Enhanced antimicrobial efficacy and energy efficiency of low irradiance 405-nm light for bacterial decontaminationArchives of Microbiology, 2024
- Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in SudanMolecular Therapy, 2021
- Human genetics of leishmania infectionsHuman Genetics, 2020
- Antimicrobial blue light inactivation of pathogenic microbes: State of the artDrug Resistance Updates, 2017
- Cytotoxic responses to 405nm light exposure in mammalian and bacterial cells: Involvement of reactive oxygen speciesToxicology in Vitro, 2016
- The efficacy of aerosol treatment with non-ionic surfactant vesicles containing amphotericin B in rodent models of leishmaniasis and pulmonary aspergillosis infectionJournal of Controlled Release, 2012
- A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasisVaccine, 2010
- The role of oxygen in the visible-light inactivation of Staphylococcus aureusJournal of Photochemistry and Photobiology B: Biology, 2008
- LeishmaniasisThe Lancet, 1999
- Resistance to Leishmania major infection correlates with the induction of nitric oxide synthase in murine macrophagesEuropean Journal of Immunology, 1991